Following tumour induction, intratumoral injections of TRH-PSi microparticles (aliquots of 2 mg of particles in 30 μl) were administered and intravital tracking was carried out to visualize and quantify the fluorescence of the labelled particles for 11 days. The gene discussed is TRH; the disease is neoplasm.